Occupational cancer burden research
HSE commissioned Dr Lesley Rushton and colleagues, from Imperial College London and colleagues frkom the Health and Safety Laboratory, the Institute of Occupational Medicine and the Institute of Environment and Health, to produce an updated and detailed estimate of the burden of occupational cancer in Great Britain. The outputs from this work will help HSE to develop and prioritise practical measures to help reduce the occupational cancer burden in the future.
This work is in two parts as follows:
Phase 1 – Current Cancer Burden
In the first phase, the current burden due to past occupational exposures was estimated for twenty three most common cancer sites: bladder, bone and thyroid, brain, breast, cervix, kidney, larynx, leukaemia, liver, lung, all lymphohaematopoietic, melanoma, mesothelioma, multiple myeloma, nasopharynx, non-Hodgkin’s lymphoma, non-melanoma skin cancer, oesophagus, ovary, pancreas, stomach, sinonasal, and soft tissue sarcoma.
An overview report and a methodology report have also been produced,
Individual reports for each cancer site can be found below,
Respiratory tract cancer
Urinary tract cancer
Other cancer site
An interim report (RR 595) was published in 2007 containing provisional estimates for the burden of cancer associated with the six identified most common cancer sites: bladder; leukaemia; lung; mesothelioma; sinonasal; and non-melanoma skin cancer. An interim overview report (RR800) was published in 2010 containing interim results for all of the cancer sites examined. The estimates contained in these reports have now been updated in the light of new information but the copies of the original reports can still be found below.
Phase 2 - Future Cancer Burden
This investigates the future cancer burden due to occupation. A methodology report was published in 2011 and a technical report summarising estimates of future cancer burdens for selected carcinogens was published in 2012.